flow trial semaglutide ppt 🔴Cardiovascular outcomes with by severity of chronic kidney disease in type 2 diabetes: the trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants 2. dr. Nanang - New

Weight loss itself can improve mood and self-esteem in some patients, while the stress of lifestyle change or social judgment around medication use can worsen mental health in others

Industry trials can be well conducted, but there are many situations where a lack of independence has had an influence on the way the study was designed and the results that are released

Glucagon-like peptide 1 (GLP-1) agonists including brand names like Ozempic and Wegovy were created to help people with type 2 diabetes make more insulin and lower their blood sugar

It is used to decrease inflammation and suppress the immune system, helping to manage conditions like asthma, arthritis, and various autoimmune disorders

78 Rates of suicide in clinical trials for T2D or obesity are very low, precluding meaningful assessment of risk with GLP-1 medicines